GE HealthCare Acquires Sofie Biosciences for $945 Million
GE HealthCare has announced the purchase of Sofie Biosciences for a substantial sum of $945 million.
"Reuters" reports this move as a strategic step to strengthen their radiopharma business.
GE HealthCare has announced the purchase of Sofie Biosciences for a substantial sum of $945 million.
"Reuters" reports this move as a strategic step to strengthen their radiopharma business.